Back to Search
Start Over
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy
- Source :
- Bone Marrow Transplantation
- Publication Year :
- 2018
- Subjects :
- 0301 basic medicine
Male
medicine.medical_specialty
Transplantation Conditioning
medicine.medical_treatment
Genetic enhancement
Twins
Hematopoietic stem cell transplantation
Hematology
Transplantation, ARSA, Gene Therapy
Defibrotide
03 medical and health sciences
0302 clinical medicine
Polydeoxyribonucleotides
Internal medicine
Correspondence
medicine
Humans
Transplantation
business.industry
Hematopoietic Stem Cell Transplantation
Hematopoietic stem cell
Genetic Therapy
Leukodystrophy, Metachromatic
Gene Therapy
medicine.disease
Metachromatic leukodystrophy
030104 developmental biology
medicine.anatomical_structure
030220 oncology & carcinogenesis
Immunology
Platelet aggregation inhibitor
ARSA
business
Platelet Aggregation Inhibitors
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Bone Marrow Transplantation
- Accession number :
- edsair.doi.dedup.....1644782068f8ef760b1e0820c59421b1